CDC Opioids Online Training

CDC has added a twelfth module to its free-CE series of online on-demand opioid training modules, Applying CDC’s Guideline for Prescribing Opioids: An Online Training Series for Healthcare Providers.  The new module is called A Nurse’s Call to Action for Safer Opioid Prescribing.  Fine the new module at, and the other eleven modules at

8/21 CDC and OHA on Infection Prevention

CDC’s webpage on the Making Dialysis Safer for Patients Coalition includes links to many posters, audit tools, checklists and fact sheets for use in providers’ offices, dialysis clinics, training sessions, work areas, and similar resources for patients.  It also includes recordings of free continuing-education webinars on infection prevention in dialysis clinics, plus past and current coalitionNEWSLETTERs.  Find this CDC web page at  CDC also publishes a Safe Healthcare Blog, at

Making Dialysis Safer Coalition

The latest Oregon One and Only Campaign Newsletter contains articles on:

  • Single-dose and multiple-dose vials, including a link to a CDC infographic on it
  • An August 21, 2019 webinar on drug diversion and a link to the Council of State and Territorial Epidemiologists’s HAI Drug Diversion Planning and Response Toolkit for State and Local Health Departments
  • An example of multiple acute HCV infections caused by using a single-dose vial for multiple patients

Find the newsletter at and the Oregon Health Authority’s HAI Prevention webpage at

8/7 CCCC Webinar on Medical Cannabis

The Coalition for Compassionate Care of California will present an August 8, 2019 webinar on Medical Cannabis: Patient Education for Safe and Effective Use.  Continuing Education credits are available for nurses and social workers.  For details and registration see

NW16 6/28 WA DOH Webinar re Drugs

The Washington State Department of Health will hold a 1pm PDT June 28, 2019 meeting and webinar on the legality of the sale, delivery, and possession of specific preparations of heparin, dialysate, and KCL or NaCl for injection (“legend drugs”: see, and other drugs, by dialysis clinics.  The purpose of the meeting is to discuss and clarify the kinds of licensing required by Washington State law.  For details see

From a meeting announcement memo: “The [Washington State] Pharmacy Commission has been asked by the [Washington] DOH Office of Health System Oversight (OHSO) for guidance on the statutory authority of ESRD or Kidney Dialysis Centers to sell, deliver, or possess legend drugs.  The Pharmacy Commission and OHSO staff would like to hold a stakeholder meeting to present initial findings from the staff research and obtain input from stakeholders.  Following the stakeholder meeting the Pharmacy Commission and OHSO staff will prepare an Interpretive Statement to provide guidance to the provider community and [DOH].”

To attend the meeting in person: Room 158, Town Center 2, Tumwater campus, 111 Israel Rd SE, Tumwater WA 98501.  To attend the meeting by webinar, register at; further instructions will be sent to you by email.  For questions or comments contact

MAC Toolkits; Transplant, Transitions, Medications

The National Forum of ESRD Networks has introduced or updated several Medical Advisory Council (MAC) Toolkits.  Two new Kits include the Transplant Toolkit and the Medication Conversion Toolkit.  The Transitions of Care Toolkit was updated in mid-April.  Find them all at, along with the existing Home Dialysis Toolkit, Medical Directors Toolkit, QAPI Toolkit, Medication Reconciliation Toolkit, Catheter Reduction Toolkit, Vaccination Toolkit, and Assurance of Diabetes Care Coordination Toolkit.

CDC and CMS Opioid Guidelines

CDC’s comprehensive resources on Applying CDC’s Guideline for Prescribing Opioids: An Online Training Series for Healthcare Providers can be found at

CMS has published “Myths and Facts” about their new Medicare Part D Opioid Overutilization Policies that became effective effective January 1, 2019 (

Myth: “Medicare is forcing all Part D enrollees to taper prescription opioids below a certain amount.”


    • Prescribers and their patients must carefully consider decisions to taper or stop prescription opioids
    • It can be especially challenging to taper opioid use in patients who have been on high dosages of opioids for many years
    • The intent of the new opioid policies is to address opioid overuse without a negative impact on the patient-doctor relationship
    • Medicare Part D opioid policies are not prescribing limits
    • In general they do not apply to enrollees who have cancer; get hospice, palliative, or end-of-life care; or who live in a long-term care facility
    • The new policies encourage collaboration and care coordination among Medicare drug plans, pharmacies, prescribers, and patients to improve opioid management, prevent opioid misuse, and promote safer prescribing practices.

For More Information see:

4/30 CCCC Webinar on Pain Management

CCCC will present an April 30, 2019 webinar on A Patient Perspective on Opioids for Chronic Pain Management: A Double-Edged Sword for Patients and Their Clinicians. For details and registration see